Proyecto de Recuperación Escombreras en 12 municipios de la provincia de Valladolid

Resumen no disponibleGrado en Ingeniería Forestal y del Medio Natura

Frozen ground and snow cover monitoring in Livingston and Deception islands, Antarctica: preliminary results of the 2015-2019 PERMASNOW project

Since 2006, our research team has been establishing in the islands of Livingston and Deception, (South Shetland archipelago, Antarctica) several monitoring stations of the active layer thickness within the international network Circumpolar Active Layer Monitoring (CALM), and the ground thermal regime for the Ground Terrestrial Network-Permafrost (GTN-P). Both networks were developed within the International Permafrost Association (IPA). In the GTN-P stations, in addition to the temperature of the air, soil, and terrain at different depths, the snow thickness is also monitored by snow poles. Since 2006, a delay in the disappearance of the snow layer has been observed, which could explain the variations we observed in the active layer thickness and permafrost temperatures. Therefore, in late 2015 our research group started the PERMASNOW project (2015-2019) to pay attention to the effect of snow cover on ground thermal This project had two different ways to study the snow cover. On the first hand, in early 2017 we deployed new instrumentation, including new time lapse cameras, snow poles with high number of sensors and a complete and complex set of instruments and sensors to configure a snow pack analyzer station providing 32 environmental and snow parameters. We used the data acquired along 2017 and 2018 years with the new instruments, together with the available from all our already existing sensors, to study in detail the snow cover. On the other hand, remote sensing data were used to try to map the snow cover, not only at our monitoring stations but the entire islands in order to map and study the snow cover distribution, as well as to start the way for future permafrost mapping in the entire islands. MODIS-derived surface temperatures and albedo products were used to detect the snow cover and to test the surface temperature. Since cloud presence limited the acquisition of valid observations of MODIS sensor, we also analyzed Terrasar X data to overcome this limitation. Remote sensing data validation required the acquirement of in situ ground-true data, consisting on data from our permanent instruments, as well as ad hoc measurements in the field (snow cover mapping, snow pits, albedo characterization, etc.). Although the project is finished, the data analysis is still ongoing. We present here the different research tasks we are developing as well as the most important results we already obtained about the snow cover. These results confirm how the snow cover duration has been changing in the last years, affecting the ground thermal behavior.Desde el año 2006, nuestro equipo de investigación ha ido estableciendo, en las islas Livingston y Decepción, en el archipiélago de las Shetland del Sur, Antártida, varias estaciones de monitorización del espesor de la capa activa, dentro de la red internacional Circumpolar Active Layer Monitoring (CALM), y del régimen térmico de los suelos para la red Ground Terrestrial Network-Permafrost (GTN-P). Ambas redes resultan de grupos de trabajo de la Asociación Internacional del Permafrost (IPA). En las estaciones GTN-P, además de la temperatura del aire, suelo, y terreno a distintas profundidades, se monitoriza, mediante termonivómetros, el espesor de la cubierta nival. Desde el año 2006 se ha ido observado un retraso en la desaparición de la capa de nieve, lo que podría explicar las variaciones que estábamos midiendo en el espesor y temperatura de la capa activa y el permafrost. Por ello, a finales de 2015 iniciamos el proyecto PERMASNOW (2015-2019) para estudiar el efecto de la capa de nieve en el régimen térmico del suelo. Este proyecto incluía dos vías para el estudio de la nieve. Por un lado, a principios de 2017 se desplegaron nuevos instrumentos en nuestras zonas de estudio, incluyendo cámaras fotográficas automáticas, termonivómetros con mayor número de sensores y un conjunto de sensores que configuran una estación para la observación de 3 variables atmosféricas y de la cubierta nival. Utilizamos los datos adquiridos a lo largo de los años 2017 y 2018 por estos nuevos instrumentos y sensores, junto con los de los demás instrumentos previamente existentes en nuestras estaciones GTN-P, para estudiar en detalle la cubierta de nieve. Por otro lado, se utilizó la teledetección para tratar de cartografiar dicha cubierta nival, no sólo en nuestras estaciones, sino también en la totalidad de estas islas con el fin conocer la distribución de la cubierta de nieve, y abrir así la vía a la futura cartografía de la distribución del permafrost en las mismas. Se utilizaron temperaturas superficiales y albedo derivadas del instrumento MODIS para detectar la cubierta de nieve y para analizar la temperatura superficial. Por otro lado, debido a la limitación de los sensores ópticos en esta región nubosa, también se utilizaron datos de radar Terrasar X. Para el análisis de datos de teledetección se tomaron datos in situ (verdad terreno) como cartografía de la capa nival, catas de nieve, mediciones de albedo, etc. Aunque el proyecto está terminado, el análisis de datos todavía está en curso. Aquí presentamos las diferentes tareas de investigación que estamos desarrollando, así como los resultados más importantes que ya hemos obtenido sobre la cubierta de nieve, que confirman cómo la duración de la cubierta de nieve ha ido cambiando en los últimos años, y está afectando al comportamiento térmico del suelo

Are Mechanical Vibrations an Effective Alternative to Accelerate Orthodontic Tooth Movement in Humans? A Systematic Review

The objective of this article was to conduct a systematic review of the literature to contrast the existing evidence on the effect of mechanical vibrations, either high or low frequency, as an alternative to accelerate orthodontic tooth movement in humans. A literature search from 2010 to June 2021 was conducted in the electronic databases: PubMed, NCBI, Google Scholar, EBSCO, Cochrane, and Ovid, using the eligibility criteria to identify the studies. Only randomized clinical trials (RCT) were included. The certainty of the evidence was assessed using the GRADE tool and the risk of bias (RoB) in individual studies was evaluated according to the Cochrane bias risk tool. Fifteen RTCs were included for final review. Overall, the RoB was classified as low (3), moderate (5), and high (7). Three articles with low RoB, four with moderate RoB, and four with high RoB found no significant effect in the use of vibrations on orthodontic movement. Only four articles, three of them with high RoB and one with moderate RoB, found that mechanical vibrations are effective at accelerating orthodontic tooth movement. The results seemed to indicate that there is no evidence that vibratory stimuli can increase the rate of dental movement or reduce neither the time of dental alignment nor canine retraction during orthodontic treatment. It is important to note that a greater number of high-quality randomized controlled trials are urgently needed

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

This work was supported by the European Union's Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845) and from the Consejería de Transformación Económica, Industria, Conocimiento y Universidades y FEDER (PY20/01282). "The Mayo studies in InterLymph were supported in part by the US National Cancer Institute grants P50 CA97274 and R01 CA92153."Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients

Competencias en comunicación médica: un arma para desmontar bulos en neurociencia

Este proyecto se diseñó con el objetivo general de favorecer la mejora en las capacidades comunicativas de los alumnos del grado en Medicina. De esta manera fomentamos que, en su futura actividad profesional, sean capaces de transmitir conocimientos y expresar argumentos de una manera clara y sencilla, pero con rigor, sabiéndose adaptar a las características concretas de cada situación y sobre todo del tipo de audiencia. Conseguimos así, una mejora en la comunicación científico-médica con compañeros de profesión, pero también en la comunicación con pacientes y sus familiares, usando un lenguaje más coloquial. En este contexto de comunicación, quisimos además proporcionar la información y herramientas necesarias para que nuestros alumnos puedan ir desarrollando habilidades que les permitan luchar contra los bulos en cuestiones de salud y más específicamente dentro del campo de la neurociencia. De esta manera, además de fomentar sus competencias transversales en comunicación, luchamos contra la neurofobia, puesto que incentivamos la pérdida del miedo a la terminología específica de las disciplinas relacionadas con el sistema nervioso, fomentando su dotes y habilidades comunicativas para expresarse también en términos divulgativos

New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

none60siOverview: We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36 University Hospitals in Europe. We performed the study in 1,307 multiple sclerosis patients (70.8% anti-John Cunninghan virus positive antibodies) treated with natalizumab for a median time of 3.28 years. Epidemiological, clinical, and laboratory variables were collected. Lipid-specific IgM oligoclonal band status was available in 277 patients. Factors associated with progressive multifocal leucoencephalopathy onset were explored by uni- and multivariate logistic regression. Results: Thirty-five patients developed progressive multifocal leucoencephalopathy. The multivariate analysis identified anti-John Cunninghan virus antibody indices and relapse rate as the best predictors for the onset of this serious opportunistic infection in the whole cohort. They allowed to stratify progressive multifocal leucoencephalopathy risk before natalizumab initiation in individual patients [area under the curve (AUC) = 0.85]. The risk ranged from &lt;1/3,300 in patients with anti-John Cunninghan virus antibody indices &lt;0.9 and relapse rate &gt;0.5, to 1/50 in the opposite case. In patients with lipid-specific IgM oligoclonal bands assessment, age at natalizumab onset, anti-John Cunninghan virus antibody indices, and lipid-specific IgM oligoclonal band status predicted progressive multifocal leucoencephalopathy risk (AUC = 0.92). The absence of lipid-specific IgM oligoclonal bands was the best individual predictor (OR = 40.94). The individual risk ranged from &lt;1/10,000 in patients younger than 45 years at natalizumab initiation, who showed anti John Cunningham virus antibody indices &lt;0.9 and lipid-specific IgM oligoclonal bands to 1/33 in the opposite case. Conclusions: In a perspective of personalized medicine, disease activity, anti-lipid specific IgM oligoclonal bands, anti Jonh Cunninghan virus antibody levels, and age can help tailor natalizumab therapy in multiple sclerosis patients, as predictors of progressive multifocal leucoencephalopathy.mixedToboso, Inmaculada; Tejeda-Velarde, Amalia; Alvarez-Lafuente, Roberto; Arroyo, Rafael; Hegen, Harald; Deisenhammer, Florian; Sainz de la Maza, Susana; Alvarez-Cermeño, José C; Izquierdo, Guillermo; Paramo, Dolores; Oliva, Pedro; Casanova, Bonaventura; Agüera-Morales, Eduardo; Franciotta, Diego; Gastaldi, Matteo; Fernández, Oscar; Urbaneja, Patricia; Garcia-Dominguez, José M; Romero, Fernando; Laroni, Alice; Uccelli, Antonio; Perez-Sempere, Angel; Saiz, Albert; Blanco, Yolanda; Galimberti, Daniela; Scarpini, Elio; Espejo, Carmen; Montalban, Xavier; Rasche, Ludwig; Paul, Friedemann; González, Inés; Álvarez, Elena; Ramo, Cristina; Caminero, Ana B; Aladro, Yolanda; Calles, Carmen; Eguía, Pablo; Belenguer-Benavides, Antonio; Ramió-Torrentà, Lluis; Quintana, Ester; Martínez-Rodríguez, José E; Oterino, Agustín; López de Silanes, Carlos; Casanova, Luis I; Landete, Lamberto; Frederiksen, Jette; Bsteh, Gabriel; Mulero, Patricia; Comabella, Manuel; Hernández, Miguel A; Espiño, Mercedes; Prieto, José M; Pérez, Domingo; Otano, María; Padilla, Francisco; García-Merino, Juan A; Navarro, Laura; Muriel, Alfonso; Frossard, Lucienne Costa; Villar, Luisa MToboso, Inmaculada; Tejeda-Velarde, Amalia; Alvarez-Lafuente, Roberto; Arroyo, Rafael; Hegen, Harald; Deisenhammer, Florian; Sainz de la Maza, Susana; Alvarez-Cermeño, José C; Izquierdo, Guillermo; Paramo, Dolores; Oliva, Pedro; Casanova, Bonaventura; Agüera-Morales, Eduardo; Franciotta, Diego; Gastaldi, Matteo; Fernández, Oscar; Urbaneja, Patricia; Garcia-Dominguez, José M; Romero, Fernando; Laroni, Alice; Uccelli, Antonio; Perez-Sempere, Angel; Saiz, Albert; Blanco, Yolanda; Galimberti, Daniela; Scarpini, Elio; Espejo, Carmen; Montalban, Xavier; Rasche, Ludwig; Paul, Friedemann; González, Inés; Álvarez, Elena; Ramo, Cristina; Caminero, Ana B; Aladro, Yolanda; Calles, Carmen; Eguía, Pablo; Belenguer-Benavides, Antonio; Ramió-Torrentà, Lluis; Quintana, Ester; Martínez-Rodríguez, José E; Oterino, Agustín; López de Silanes, Carlos; Casanova, Luis I; Landete, Lamberto; Frederiksen, Jette; Bsteh, Gabriel; Mulero, Patricia; Comabella, Manuel; Hernández, Miguel A; Espiño, Mercedes; Prieto, José M; Pérez, Domingo; Otano, María; Padilla, Francisco; García-Merino, Juan A; Navarro, Laura; Muriel, Alfonso; Frossard, Lucienne Costa; Villar, Luisa

New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

Overview: We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36 University Hospitals in Europe. We performed the study in 1,307 multiple sclerosis patients (70.8% anti-John Cunninghan virus positive antibodies) treated with natalizumab for a median time of 3.28 years. Epidemiological, clinical, and laboratory variables were collected. Lipid-specific IgM oligoclonal band status was available in 277 patients. Factors associated with progressive multifocal leucoencephalopathy onset were explored by uni- and multivariate logistic regression. Results: Thirty-five patients developed progressive multifocal leucoencephalopathy. The multivariate analysis identified anti-John Cunninghan virus antibody indices and relapse rate as the best predictors for the onset of this serious opportunistic infection in the whole cohort. They allowed to stratify progressive multifocal leucoencephalopathy risk before natalizumab initiation in individual patients [area under the curve (AUC) = 0.85]. The risk ranged from 0.5, to 1/50 in the opposite case. In patients with lipid-specific IgM oligoclonal bands assessment, age at natalizumab onset, anti-John Cunninghan virus antibody indices, and lipid-specific IgM oligoclonal band status predicted progressive multifocal leucoencephalopathy risk (AUC = 0.92). The absence of lipid-specific IgM oligoclonal bands was the best individual predictor (OR = 40.94). The individual risk ranged from <1/10,000 in patients younger than 45 years at natalizumab initiation, who showed anti John Cunningham virus antibody indices <0.9 and lipid-specific IgM oligoclonal bands to 1/33 in the opposite case. Conclusions: In a perspective of personalized medicine, disease activity, anti-lipid specific IgM oligoclonal bands, anti Jonh Cunninghan virus antibody levels, and age can help tailor natalizumab therapy in multiple sclerosis patients, as predictors of progressive multifocal leucoencephalopath